Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
He S. Yang, Sabrina Racine‐Brzostek, Mohsen Karbaschi, Jim Yee, Alicia Dillard, Peter A.D. Steel, William T. Lee, Kathleen A. McDonough, Yuqing Qiu, Thomas J. Ketas, Erik Francomano, Per Johan Klasse, Layla Hatem, Lars F. Westblade, Heng Wu, Haode Chen, Robert Zuk, Hong Yien Tan, Roxie C. Girardin, Alan P. Dupuis, Anne F. Payne, John P. Moore, Melissa M. Cushing, Amy Chadburn, Zhen Zhao
Topics & Concepts
AntibodyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibodyCoronavirus disease 2019 (COVID-19)StreptavidinVirologyImmunoassayViral loadSurrogate endpointNeutralizationImmunologyInternal medicineBiologyVirusInfectious disease (medical specialty)BiotinDiseaseGeneticsSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies